Medicinal Products

Erlotinib Mylan 150 mg filmom obložene tablete

Name Erlotinib Mylan 150 mg filmom obložene tablete
Marketing Authorisation Number HR-H-088638189
Active Substance erlotinibum
Pharmaceutical Form filmom obložena tableta
Strength 150 mg
Packaging [MA Number for Packaging] 30 tableta u perforiranom blisteru s jediničnom dozom, u kutiji  [HR-H-088638189-01]
30 tableta u blisteru, u kutiji  [HR-H-088638189-02]
Manufacturer Remedica Ltd., Limassol, Cipar
Marketing Authorisation Holder Mylan S.A.S., 117 allee des Parcs, Saint Priest, Francuska
Marketing Authorisation Date 27.06.2017
MA Period of Validity 27.06.2022
Classification Number UP/I-530-09/16-01/113
Registration Number 381-12-01/70-17-05
Composition jedna filmom obložena tableta sadrži 150 mg erlotiniba (u obliku erlotinibklorida)
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code L01XE03
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Brošura za zdravstvene radnike, verzija 2
Back